97.40000 CHF
1.2944
1.35%
Last update Dec 15, 4:19 PM GMT
Market closed
Day range
95.30000
97.40000
Previous close
96.10556
Open
97.40000
Access this stock data via API
Subscribe
Cosmo Pharmaceuticals N.V.
97.40
1.29
1.35%

Overview

Access /time_series data via our API — starting from the Basic plan.

Description

Cosmo Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing treatments for gastrointestinal diseases and procedures. Their primary purpose is to innovate and market products that improve medical treatments in the gastroenterology sector, significantly impacting patient management in this area. Cosmo Pharmaceuticals is known for its development of proprietary drug delivery technologies that enhance the effectiveness of their therapeutic offerings, particularly in the treatment of inflammatory bowel diseases and colonoscopy procedures. Headquartered in Italy, the company's work is pivotal in the pharmaceutical industry, especially in providing advanced solutions for conditions affecting the digestive system. Furthermore, their advancements contribute to the broader healthcare market by potentially reducing hospital stays and improving patient quality of life. Through licensing agreements and strategic collaborations, Cosmo Pharmaceuticals plays a crucial role in shaping the landscape of gastrointestinal therapies globally.

About

CEO
Mr. Giovanni Di Napoli
Employees
332
Address
Riverside II
Sir John Rogerson’s Quay
Dublin, 2
Phone
353 1 817 0370
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
United Kingdom
MIC code
XLON
Access /profile data via our API — starting from the Grow plan.
Market closed

Exchange is currently closed
Pre-market opens in 11 hours 21 minutes

19:53
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).